Int. J. Mol. Sci. 2012, 13(7), 8430-8448; doi:10.3390/ijms13078430

Effect of PACAP in Central and Peripheral Nerve Injuries

1,* email, 1email, 2email, 2email, 2email, 3email, 2, 1,2email, 4email, 2email, 2,† and 2,†
Received: 11 May 2012; in revised form: 25 June 2012 / Accepted: 26 June 2012 / Published: 6 July 2012
(This article belongs to the Special Issue Neuroprotective Strategies 2012)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Pituitary adenylate cyclase activating polypeptide (PACAP) is a bioactive peptide with diverse effects in the nervous system. In addition to its more classic role as a neuromodulator, PACAP functions as a neurotrophic factor. Several neurotrophic factors have been shown to play an important role in the endogenous response following both cerebral ischemia and traumatic brain injury and to be effective when given exogenously. A number of studies have shown the neuroprotective effect of PACAP in different models of ischemia, neurodegenerative diseases and retinal degeneration. The aim of this review is to summarize the findings on the neuroprotective potential of PACAP in models of different traumatic nerve injuries. Expression of endogenous PACAP and its specific PAC1 receptor is elevated in different parts of the central and peripheral nervous system after traumatic injuries. Some experiments demonstrate the protective effect of exogenous PACAP treatment in different traumatic brain injury models, in facial nerve and optic nerve trauma. The upregulation of endogenous PACAP and its receptors and the protective effect of exogenous PACAP after different central and peripheral nerve injuries show the important function of PACAP in neuronal regeneration indicating that PACAP may also be a promising therapeutic agent in injuries of the nervous system.
Keywords: endogenous; injury; neuroprotection; pituitary adenylate cyclase activating polypeptide; trauma
PDF Full-text Download PDF Full-Text [145 KB, uploaded 19 June 2014 04:21 CEST]

Export to BibTeX |

MDPI and ACS Style

Tamas, A.; Reglodi, D.; Farkas, O.; Kovesdi, E.; Pal, J.; Povlishock, J.T.; Schwarcz, A.; Czeiter, E.; Szanto, Z.; Doczi, T.; Buki, A.; Bukovics, P. Effect of PACAP in Central and Peripheral Nerve Injuries. Int. J. Mol. Sci. 2012, 13, 8430-8448.

AMA Style

Tamas A, Reglodi D, Farkas O, Kovesdi E, Pal J, Povlishock JT, Schwarcz A, Czeiter E, Szanto Z, Doczi T, Buki A, Bukovics P. Effect of PACAP in Central and Peripheral Nerve Injuries. International Journal of Molecular Sciences. 2012; 13(7):8430-8448.

Chicago/Turabian Style

Tamas, Andrea; Reglodi, Dora; Farkas, Orsolya; Kovesdi, Erzsebet; Pal, Jozsef; Povlishock, John T.; Schwarcz, Attila; Czeiter, Endre; Szanto, Zalan; Doczi, Tamas; Buki, Andras; Bukovics, Peter. 2012. "Effect of PACAP in Central and Peripheral Nerve Injuries." Int. J. Mol. Sci. 13, no. 7: 8430-8448.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert